The Frequency of Epidermal Growth Factor Receptor Mutation of Nonsmall Cell Lung Cancer according to the Underlying Pulmonary Diseases

Background. Although epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) are effective in patients with nonsmall cell lung cancer with epidermal growth factor receptor (EGFR) mutation, EGFR-TKIs have a risk of inducing fatal interstitial lung disease (ILD). The selection of chemo...

Descripción completa

Detalles Bibliográficos
Autores principales: Usui, Kazuhiro, Ushijima, Tomonori, Tanaka, Yoshiaki, Tanai, Chiharu, Noda, Hiromichi, Abe, Norifumi, Horiuchi, Hajime, Ishihara, Teruo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2011
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3236312/
https://www.ncbi.nlm.nih.gov/pubmed/22191026
http://dx.doi.org/10.1155/2011/290132

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3236312/
https://www.ncbi.nlm.nih.gov/pubmed/22191026
http://dx.doi.org/10.1155/2011/290132

Ejemplares similares